Depletion of high-affinity corticosteroid-binding globulin corresponds to illness severity in sepsis and septic

M A Nenke1,2, W Rankin3, M J Chapman4

  • 1Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, SA, Australia.

Clinical Endocrinology
|November 21, 2014
PubMed

Insights

In sepsis, high-affinity corticosteroid-binding globulin (haCBG) levels decrease significantly with illness severity. This reduction in haCBG may impair cortisol delivery to inflammatory sites, potentially worsening sepsis outcomes.

Area of Science:

  • Endocrinology
  • Immunology
  • Critical Care Medicine

Background:

  • Corticosteroid-binding globulin (CBG) exists in high-affinity (haCBG) and low-affinity (laCBG) conformations.
  • Neutrophil elastase cleaves CBG, converting haCBG to laCBG, which has reduced cortisol-binding affinity.
  • In vitro studies suggest CBG cleavage facilitates targeted cortisol delivery to inflammation.

Purpose of the Study:

  • To investigate in vivo whether CBG cleavage alters circulating haCBG and laCBG levels in sepsis patients.
  • To correlate CBG conformation levels with sepsis severity.

Main Methods:

  • Prospective, observational cohort study in an adult Intensive Care Unit.
  • Recruited 33 patients with sepsis or septic shock, categorized by illness severity.
  • Measured plasma haCBG, laCBG, total cortisol, and free cortisol using in-house assays.

Main Results:

  • Plasma total CBG and haCBG levels significantly decreased with increasing sepsis severity (P < 0.0001).
  • Free and total cortisol levels showed a nonsignificant trend of increase with worsening illness severity.
  • haCBG levels correlated better with illness severity than free or total cortisol.

Conclusions:

  • Circulating haCBG concentrations are markedly reduced in vivo in patients with increasing sepsis and septic shock severity.
  • Low haCBG levels in chronic inflammation may limit cortisol availability at inflammatory sites.
  • This limitation could potentially perpetuate the inflammatory process in sepsis.
Abstract

Related Concept Videos

Acute Inflammation II: Local and Systemic Effects01:25

Acute Inflammation II: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
7
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
1
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
4.4K
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
13
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
13.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.6K